Option Care Health (NASDAQ:OPCH) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Option Care Health (NASDAQ:OPCH) had its target price increased by stock analysts at JPMorgan Chase & Co. from $40.00 to $41.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price points to a potential upside of 20.55% from the stock’s previous close.

Several other brokerages also recently commented on OPCH. Barrington Research lifted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. UBS Group assumed coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $33.00.

Option Care Health Trading Down 0.7 %

OPCH stock opened at $34.01 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a one year low of $21.39 and a one year high of $34.85. The company’s 50 day moving average price is $29.83 and its two-hundred day moving average price is $28.20. The company has a market capitalization of $5.62 billion, a PE ratio of 28.58, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33.

Insider Activity at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.64% of the stock is currently owned by company insiders.

Institutional Trading of Option Care Health

Hedge funds have recently modified their holdings of the business. Westfield Capital Management Co. LP boosted its holdings in shares of Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after buying an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. boosted its holdings in shares of Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after buying an additional 25,905 shares in the last quarter. Graypoint LLC bought a new position in Option Care Health in the 4th quarter worth about $1,161,000. Victory Capital Management Inc. boosted its stake in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares in the last quarter. Finally, Barclays PLC boosted its stake in Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after purchasing an additional 199,454 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.